CEA-targeting CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEA-targeting CAR-T cell therapy, covering 2024-08-09 to 2024-08-09. Get the full timeline:
Most recent: Clinical Trial Update: CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors [Phase 1, Phase 2]